Brainstorm Cell Therapeutics reported $-2.24M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
Biogen USD 514.3M 128.8M Mar/2026
Brainstorm Cell Therapeutics USD -2.24M 197K Dec/2025
Cipla INR 6.14B 3.63B Mar/2026
Clal Biotechnology ILS -1.74M 7.46M Dec/2022
Compugen USD 56.04M 63.93M Dec/2025
CSL USD 2.64B 1.97B Dec/2025
Cytokinetics USD -181.23M 2.86M Mar/2026
Gilead Sciences USD 2.68B 284M Mar/2026
Grifols EUR 320.55M 91.01M Dec/2025
Halozyme Therapeutics USD -61.77M 26.64M Mar/2026
Mesoblast USD -30.96M 11.14M Dec/2025